← FDA Drug Approvals (Drugs@FDA)

SITAGLIPTIN AND METFORMIN HCL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA LTD · Approved 2024-12-11

Drug application

FDA Application #

ANDA218971

Application type

Abbreviated New Drug Application (Generic)

Brand name

SITAGLIPTIN AND METFORMIN HCL

Generic name

Sitagliptin, Metformin Hydrochloride

Active ingredients

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

MANKIND PHARMA LTD

First approval

2024-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown